Leerink Swann Downgrades Amicus Therapeutics (FOLD) to Market Perform
Tweet Send to a Friend
Leerink Swann downgraded Amicus Therapeutics (NASDAQ: FOLD) from Outperform to Market Perform with a price target of $3.00.
Analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
